Type II Diabetes Mellitus
5 competing products in clinical development for Type II Diabetes Mellitus.
Pipeline by Phase
Phase 12
Phase 21
Phase 32
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| GL0034 Dose Level 1 + GL0034 Dose Level 2 + GL0034 Dose Level 3 + GL0034 Dose Level 4 + GL0034 Dose Level 5 + GL0034 Dose Level 6 | Sun Pharmaceutical | Phase 2 | Recruiting | 42 |
| ASP1941 + metformin + Placebo | Astellas Pharma | Phase 3 | Completed | 40 |
| GL0034 | Sun Pharmaceutical | Phase 1 | Recruiting | 36 |
| ASP1941 + acarbose + Placebo | Astellas Pharma | Phase 3 | Terminated | 32 |
| Daily injection of KBP/placebo for up to 28 days | Eli Lilly | Phase 1 | Terminated | 21 |